Latest News
December 20, 2017
Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) as Adjuvant Therapy in Patients with Completely Resected Melanoma with Lymph Node Involvement or Metastatic Disease
December 20, 2017
TARIS and Bristol-Myers Squibb Announce Clinical Trial Collaboration
December 19, 2017
Bristol-Myers Squibb to Announce Results for Fourth Quarter 2017 on February 5th
Latest Events
Event year list
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
December 6, 2017
02:55 PM ET
Citi 2017 Global Healthcare Conference
November 29, 2017
11:45 AM ET
2017 Evercore ISI Biopharma Catalyst/Deep Dive Conference
November 15, 2017
10:40 AM GMT
Jefferies 2017 London Healthcare Conference